Abstract
(Anesth Analg. 2017;124(4):1211–1218) Remifentanil is a short-acting opioid. Its use for labor analgesia is controversial because of reports of associated apnea. The aim of this study was to perform a secondary analysis of respiratory data from a previous study of laboring women using patient-controlled intravenous (IV) remifentanil analgesia, in order to evaluate physiologic variables as early warning alerts of apnea.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
